Cwm, LLC Novavax Inc Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Novavax Inc stock. As of the latest transaction made, Cwm, LLC holds 1,768 shares of NVAX stock, worth $15,045. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,768

Previous 1,452 21.76%

Holding current value

$15,045

Previous $18,000 22.22%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$10.71 - $17.11 $3,384 - $5,406	316 Added 21.76%	1,768 $22,000
Q2 2024 Jul 09, 2024	SELL	$3.89 - $20.97 $1,431 - $7,716	-368 Reduced 20.22%	1,452 $18,000
Q1 2024 Apr 05, 2024	BUY	$3.76 - $6.02 $2,150 - $3,443	572 Added 45.83%	1,820 $9,000
Q4 2023 Feb 01, 2024	SELL	$4.8 - $7.67 $1,190 - $1,902	-248 Reduced 16.58%	1,248 $6,000
Q3 2023 Oct 11, 2023	BUY	$6.81 - $9.74 $1,695 - $2,425	249 Added 19.97%	1,496 $11,000
Q2 2023 Aug 03, 2023	BUY	$6.67 - $9.52 $673 - $961	101 Added 8.81%	1,247 $9,000
Q1 2023 Apr 28, 2023	SELL	$5.76 - $12.48 $1,491 - $3,232	-259 Reduced 18.43%	1,146 $8,000
Q4 2022 Feb 01, 2023	BUY	$8.86 - $25.04 $5,236 - $14,798	591 Added 72.6%	1,405 $14,000
Q3 2022 Oct 27, 2022	BUY	$18.2 - $76.12 $4,004 - $16,746	220 Added 37.04%	814 $15,000
Q2 2022 Jul 28, 2022	SELL	$36.28 - $75.29 $1,015 - $2,108	-28 Reduced 4.5%	594 $31,000
Q1 2022 Apr 21, 2022	SELL	$69.73 - $142.9 $52,715 - $108,032	-756 Reduced 54.86%	622 $46,000
Q4 2021 Jan 31, 2022	BUY	$134.56 - $217.97 $100,247 - $162,387	745 Added 117.69%	1,378 $197,000
Q1 2021 Sep 15, 2021	BUY	$112.98 - $319.93 $11,298 - $31,993	100 Added 18.76%	633 $134,000
Q1 2021 Apr 27, 2021	SELL	$112.98 - $319.93 $11,298 - $31,993	-100 Reduced 15.8%	533 $97,000
Q4 2020 Sep 15, 2021	SELL	$78.74 - $139.5 $30,944 - $54,823	-393 Reduced 38.3%	633 $134,000
Q4 2020 Jan 27, 2021	BUY	$78.74 - $139.5 $30,944 - $54,823	393 Added 62.09%	1,026 $114,000
Q3 2020 Sep 15, 2021	BUY	$79.44 - $178.51 $8,500 - $19,100	107 Added 20.34%	633 $134,000
Q3 2020 Oct 19, 2020	SELL	$79.44 - $178.51 $8,500 - $19,100	-107 Reduced 16.9%	526 $57,000
Q2 2020 Sep 15, 2021	BUY	$13.86 - $83.61 $8,080 - $48,744	583 Added 1166.0%	633 $134,000
Q2 2020 Jul 22, 2020	SELL	$13.86 - $83.61 $8,080 - $48,744	-583 Reduced 92.1%	50 $4,000
Q1 2020 Sep 15, 2021	BUY	$3.93 - $16.0 $2,291 - $9,328	583 Added 1166.0%	633 $134,000
Q1 2020 Apr 28, 2020	SELL	$3.93 - $16.0 $2,291 - $9,328	-583 Reduced 92.1%	50 $1,000
Q4 2019 Sep 14, 2021	BUY	$3.69 - $5.22 $2,332 - $3,299	632 Added 63200.0%	633 $134,000
Q4 2019 Jan 27, 2020	SELL	$3.69 - $5.22 $2,332 - $3,299	-632 Reduced 99.84%	1 $0
Q3 2019 Sep 14, 2021	BUY	$4.02 - $7.84 $2,544 - $4,962	633 New	633 $134,000
Q3 2019 Oct 22, 2019	SELL	$4.02 - $7.84 $2,544 - $4,962	-633 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$4.93 - $12.2 $3,120 - $7,722	633 New	633 $134,000
Q2 2019 Jul 31, 2019	SELL	$4.93 - $12.2 $3,120 - $7,722	-633 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$10.2 - $46.8 $6,456 - $29,624	633 New	633 $0

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account